DAM
MNTA

DLD Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

DLD Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-494,260
Closed -$25.9M – 122
2020
Q3 		$25.9M Buy
+494,260
New +$20.5M 0.6% 18

DLD Asset Management's MNTA Position: Q4 2020 in Review

DLD Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 494,260 shares — an estimated $25.9M sold.

DLD Asset Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $25.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • DLD Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • DLD Asset Management sold 494,260 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $25.9M.
  • DLD Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • DLD Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $25.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on DLD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.